Your browser doesn't support javascript.
loading
The effects of ketamine on typical and atypical depressive symptoms.
Park, L T; Luckenbaugh, D A; Pennybaker, S J; Hopkins, M A; Henter, I D; Lener, M S; Kadriu, B; Ballard, E D; Zarate, C A.
Afiliação
  • Park LT; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, Bethesda, MD, USA.
  • Luckenbaugh DA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, Bethesda, MD, USA.
  • Pennybaker SJ; Equity, Diversity, and Inclusion, Office of the Director, National Institutes of Health, Bethesda, MD, USA.
  • Hopkins MA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, Bethesda, MD, USA.
  • Henter ID; University of California, San Francisco, CA, USA.
  • Lener MS; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, Bethesda, MD, USA.
  • Kadriu B; Department of Psychiatry, Georgetown University, Washington, DC, USA.
  • Ballard ED; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, Bethesda, MD, USA.
  • Zarate CA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, Bethesda, MD, USA.
Acta Psychiatr Scand ; 142(5): 394-401, 2020 11.
Article em En | MEDLINE | ID: mdl-32677051

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Transtorno Depressivo Resistente a Tratamento / Ketamina Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Transtorno Depressivo Resistente a Tratamento / Ketamina Idioma: En Ano de publicação: 2020 Tipo de documento: Article